Health Scope

Published by: Kowsar

Drug Demand Function for Iranian Urban Households Based on Households' Budget

Ramin Ravangard 1 , Abdosaleh Jafari 1 , * and Soraya Nouraei Motlagh 2
Authors Information
1 Health Human Resource Research Center, School of Management and Information Sciences, Shiraz University of Medical Sciences, Shiraz, IR Iran
2 Department of Health Economics, School of Health Management and Information Sciences, Tehran University of Medical Sciences, Tehran, IR Iran
Article information
  • Health Scope: August 15, 2014, 3 (3); e18494
  • Published Online: August 10, 2014
  • Article Type: Research Article
  • Received: February 23, 2014
  • Revised: June 20, 2014
  • Accepted: May 17, 2014
  • DOI: 10.17795/jhealthscope-18494

To Cite: Ravangard R, Jafari A, Nouraei Motlagh S. Drug Demand Function for Iranian Urban Households Based on Households' Budget, Health Scope. 2014 ; 3(3):e18494. doi: 10.17795/jhealthscope-18494.

Copyright © 2014, Health Promotion Research Center. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
  • 1. Hashemi Fesharaki M. The Role of Medical Services and Prescriptions Review Committees in Explaining the Supply and Demand Conditions of Iran Pharmaceutical Market. First Conference on Health Economics. 1999;
  • 2. Best practice in HIV/AIDS prevention and care for injecting drug abusers, The Triangular Clinic in Kermanshah, Islamic Republic of Iran. 2004;
  • 3. Noorayimotlagh S. Estimation of Drug Demand in Iran based on the Household Budget Data from 1997 to 2006. 2009;
  • 4. Nissaramanesh B, Trace M, Roberts M. The rise of harm reduction in the Islamic Republic of Iran Briefing Paper. Beckley Found Drug Policy Programme. 2005; 8
  • 5. Effectiveness of Sterile Needle and Syringe Programming in Reducing HIV/AIDS among Injecting Drug Users Evidence for action technical papers. 2004;
  • 6. Logan TK, Hoyt WH, McCollister KE, French MT, Leukefeld C, Minton L. Economic evaluation of drug court: Methodology, results, and policy implications. Eval Program Plann. 2004; 27(4): 381-96[DOI]
  • 7. Marsch LA. The efficacy of methadone maintenance interventions in reducing illicit opiate use, HIV risk behavior and criminality: a meta-analysis. Addiction. 1998; 93(4): 515-32[PubMed]
  • 8. Ghahremani Saghir H. How to prevent excessive consumption of drugs? First Symposium of National Resources Loss Prevention. 2004;
  • 9. Competitive mechanisms for public drug supply: options, issues, and cautions (working draft). 1997;
  • 10. Klick J, Stratmann T. How Sensitive are Seniors to the Price of Prescription Drugs? Public Law Research Paper. 2005;
  • 11. Duggan M. Do new prescription drugs pay for themselves? The case of second-generation antipsychotics. J Health Econ. 2005; 24(1): 1-31[DOI][PubMed]
  • 12. Atherly A. Supplemental insurance: Medicare's accidental stepchild. Med Care Res Rev. 2001; 58(2): 131-61[PubMed]
  • 13. Smith DG, Kirking DM. Impact of consumer fees on drug utilisation. Pharmacoeconomics. 1992; 2(4): 335-42[PubMed]
  • 14. Ettner SL. Adverse selection and the purchase of Medigap insurance by the elderly. J Health Econ. 1997; 16(5): 543-62[PubMed]
  • 15. Glazer WM, Johnstone BM. Pharmacoeconomic evaluation of antipsychotic therapy for schizophrenia. J Clin Psychiatry. 1997; 58 Suppl 10: 50-4[PubMed]
  • 16. Greene WH. Econometric analysis. 2003;
  • 17. Ebadifard Azar F, Rezapoor A, Rahbar A, Shokouh H, Morteza S. Estimation of the Function of Medicine Demand in Islamic Republic of Iran. J Mil Med. 2013; 15(2): 163-8
  • 18. Rahbar A, Barouni M, Bahrami M, Saber Mahani A. Estimation of Drug Demand Function in Iranian Urban Population through Household Budget, 1990-2011. J Tolooe Behdasht. 2013; 12(3): 44-58
  • 19. Chalmers J, Bradford D, Jones C. The effect of methamphetamine and heroin price on polydrug use: A behavioural economics analysis in Sydney, Australia. Int J Drug Policy. 2010; 21(5): 381-9[DOI][PubMed]
  • 20. Bishai D, Sindelar J, Ricketts EP, Huettner S, Cornelius L, Lloyd JJ, et al. Willingness to pay for drug rehabilitation: implications for cost recovery. J Health Econ. 2008; 27(4): 959-72[DOI][PubMed]
  • 21. Liu JL, Liu JT, Hammitt JK, Chou SY. The price elasticity of opium in Taiwan, 1914-1942. J Health Econ. 1999; 18(6): 795-810[PubMed]
  • 22. Van Ours JC. The price elasticity of hard drugs: The case of opium in the Dutch East Indies, 1923-1938. J Polit Econ. 1995; 103(2): 261-79[DOI]
  • 23. Nisbet CT, Vakil F. Some estimates of price and expenditure elasticities of demand for marijuana among UCLA students. Rev Econ Stat. 1972; 54(4): 473-5[DOI]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments